Results: We obtained 60 responses from immunologist/allergists (53.3%), immunology/allergy nurses (23.3%), immunology/allergy trainees (5.0%) and other doctors with an interest in immunology/allergy (18.3%). Of these, 41.7% worked mainly with children, 33.3% with adults and 25% with both. Those working with adults were more likely to recommend devices more than once per month compared to those working with children (85.0% vs 52.0%). Most (71.4%) recommended medical alert devices for patients with drug allergy often or routinely, compared to 45.6% for venom allergy and 34.5% for food allergy. A history of anaphylaxis was considered the most important indication for a device for all categories of allergy (drug (88.3%), food (68.3%), venom (75%)). The majority of doctors (76.1%) considered drug-induced severe cutaneous adverse reaction (SCAR) to be an indication for a device. Those working with adults were more likely to consider food anaphylaxis an indication for a device, compared to those working with children (90.0% vs 64.0%). 86.7% of respondents agreed that allergy information should be medically validated.
Conclusion: Medical alert devices are commonly recommended by allergy professionals. The devices may be of highest value in those with a history of anaphylaxis or SCAR. We propose there should be guidelines regarding the indications and terminology for use in allergy, and that this information be medically validated. Background: Drug, food and venom allergies are potentially life threatening and are increasing in prevalence in Australia. Appropriate communication of these allergies is vital; one modality available to affected individuals is to wear MedicAlert 'jewellery'. The usefulness of such devices to emergency health care workers (HCW) has not been studied.
P71 USE OF MEDICALERTS DEVICES BY HEALTH CARE WORKERS IN THE COMMUNICATION OF ALLERGY

Aim:
Our study aimed to identify how HCW use MedicAlerts for drug allergy notification, and what information is vital for safe prescription of medications.
Method:
The authors developed a survey exploring the level of recognition of MedicAlert devices, the terminology used and influence on prescribing decisions. The surveys were distributed to 100 HCW including nursing staff, junior medical officers (JMOs), medical registrars, emergency department (ED) officers, medical consultants, general practitioners and first responders. These survey responses were analysed according to HCW group.
Results: ED officers were more aware of, and checked more often for, MedicAlerts than JMOs and nurses (52% versus 30% and 45% respectively). First responders found a lack of usefulness in emergency situations (70% stating never or sometimes useful). No GPs were aware of being able to contact MedicAlert via phone for more information, but 85% stated access to more information would change their prescribing decisions. The main limitations to MedicAlert use were non-specific terminology (42%) and concerns regarding the information not being medically validated (40%). Very few respondents (22%) were aware that further information could be obtained from the MedicAlert Foundation via telephone. Wording of reaction had an influence on prescribing decisions, with 20% of prescribers never prescribing a third generation cephalosporin based on the wording 'Penicillin-Allergy', compared to 5% based on 'Penicillin-Rash'
Conclusion:
The MedicAlert can be a useful communication tool, but it is in need of standardisation of terminology and medical verification, to improve clarity and accuracy. Hanoi Heart Hospital, Hanoi, Vietnam Introduction: HLA-B*58:01 is strongly associated with allopurinolinduced severe cutaneous adverse reactions (SCAR) including StevenJohnson Syndrome/Toxic epidermal Necrolysis (SJS/TEN) and Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (HSS/DRESS). However, most individuals (97%), who harbor HLA-B*58:01 tolerate allopurinol indicating that other factors contribute to its pathogenesis. Furthermore, HLA-B*58:01 is not phenotype specific with patients developing either SJS/TEN or HSS/DRESS. We performed gene expression studies to determine the molecular processes that confer susceptibility to SCAR and ascertain any differences between SJS/TEN and HSS/DRESS patients.
P72 GENE PROFILING STUDIES DEMONSTRATE THE ROLE OF INNATE IMMUNE RESPONSES IN ALLOPURINOL-INDUCED SEVERE CUTANEOUS ADVERSE REACTIONS
Methodology: Total RNA was extracted from peripheral blood mononuclear cells of patients with allopurinol-induced SCAR and tolerant controls. Microarrays were performed on 11 RNA samples (4 SJS/TEN, 3 HSS/DRESS, 4 controls). The Partex ® genomics suite (v6.6) was used to identify expressed genes and pathways, followed by quantitative realtime PCR (qPCR) on 19 samples (8 SJS/TEN, 4 HSS/DRESS, 7 controls). REST software was used to calculate the relative expression.
Results: HLA-B*58:01 was present in all patients and 2 selected controls. Gene profiling showed high expression of the cell cycle-related histone linker H1.5 gene (6.479-fold, P = 0.005) in SCAR patients. Also, high expression of miR146a was observed in HLA-B*58:01 positive controls compared to SCAR patients (3.700-fold, P = 0.33).
Comparing the 2 patient groups, TLR7 and TLR4 were downregulated in HSS/DRESS while only low expression of TLR7 was found in SJS/TEN. Furthermore, several genes such as IL-10 (6.345-fold, P = 0.035), MMP8 (9.531-fold, P = 0.021), and MMP9 (5.561-fold, P = 0.032), which encode for alarmins were highly expressed in SJS/TEN.
Conclusion:
Gene expression studies demonstrate the important role of certain innate immune responses in allopurinol-induced SCAR. These include histone linker H1.5, a crucial factor for dendritic cell maturation and T-cell proliferation; miR146a, a negative regulator of innate immunity and alarmins, chemotactic activators of immune responses. Further studies are being conducted to determine the significance of these findings. Background: Hair dye is a popular cosmetic product nowadays. Many strong and extreme sensitising chemicals, such as para-phenylenediamine (PPD), toluene-2,5-diamine (TDA) and other aromatic amines or crossreacting substances, are ingredients in hair dye products.
P73 CONTACT ALLERGY TO HAIR DYES (P-
Objectives: To study the clinical patterns and PPD contact sensitivity in patients with hair-dye dermatitis.
Materials and methods: Ninety five (M:F 56:39) consecutive patients aged between 18 and 70 years suspected to have contact allergy from hair dye were studied by patch testing standard patch test series including pphenylenediamine (PPD, 1.0% pet).
Results: Seventy-six (M:F 39:36) patients showed positive patch tests from PPD. Twenty-one of these patients also showed positive patch test reaction from fragrance mix, thiuram mix, paraben mix, or colophony. Fifty-six (74%) patients affected were aged older than 40 years. The duration of dermatitis varied from <1 month to >1 year with exacerbation following hair coloring. Fifty-three (70%) patients had dermatitis of scalp and/or scalp margins and 22 patients (30%) had face and neck dermatitis. 
